Ratings by Leerink Partners (Kenneth Shields)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
5/16/2023 CTI BioPharma CTIC Downgrade Market Perform
(Outperform)
8.96
(9.09)
1.45% Details